TABLE 5.
Pathologic extent of disease.
Factor | No. of patients (%) |
---|---|
Pathologic extent of disease | |
Bone invasion | |
Absent | 38 (52.8) |
Present | 31 (43.1) |
Not examined | 3 (4.2) |
Perineural invasion | |
Absent | 39 (54.2) |
Present | 29 (40.3) |
Not examined | 4 (5.6) |
Lymphatic invasion | |
Absent | 14 (19.4) |
Present | 6 (8.3) |
Not examined | 52 (72.2) |
Angioinvasion | |
Absent | 20 (27.8) |
Present | 17 (23.6) |
Not examined | 35 (48.6) |
Parotid invasion* | |
Absent | 25 (61.0) |
Present | 14 (34.1) |
Not examined | 2 (4.9) |
Depth of invasion | |
<1 mm | 13 (18.1) |
1 mm | 9 (12.5) |
Not examined | 50 (69.4) |
Margin status | |
Negative | 42 (58.3) |
Close or positive | 30 (41.7) |
Parotid nodal status* | |
Negative | 21 (51.2) |
Positive | 7 (17.1) |
Not examined | 13 (31.7) |
Pittsburgh T classification | |
pT0† | 8 (11.1) |
pT1 | 17 (23.6) |
pT2 | 2 (2.9) |
pT3 | 12 (16.7) |
pT4 | 30 (41.7) |
Not examined | 3 (4.2) |
N classification‡ | |
pN0 | 38 (86.4) |
pN+ | 6 (13.6) |
Excluding primary parotid tumors.
Cutaneous primary not clinically involving external auditory canal/temporal bone.
Neck dissection specimens.